A vaccine against tuberculosis, the world’s deadliest infectious disease, has never been closer to reality, with the potential to save millions of lives. But its development slowed after its corporate owner focused on more profitable vaccines.
The worst part is how prevalent this is across every industry imaginable. Anything remotely advantageous to humanity is and will continue to be second to profit.